SCHEMBL23218474

SCHEMBL23218474

CCOC(=O)Cc1ccccc1OCc1nn(C(C)C)c2ccc(-c3cc(CN)cc(C4CCN(C)CC4)c3)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFD P00746 8/20 0.47
F11 P03951 6/20 0.34
TPSB2 P20231 4/20 0.34
KLKB1 P03952 3/20 0.34
PLG P00747 2/20 0.34
PLAU P00749 2/20 0.34
F7 P08709 2/20 0.34
TBXAS1 P24557 1/20 0.34
F2 P00734 1/20 0.33
F9 P00740 1/20 0.33
F10 P00742 1/20 0.33
PLAT P00750 1/20 0.33
PTGS1 P23219 1/20 0.33
SLC18A2 Q05940 1/20 0.33
PDE4D Q08499 1/20 0.33
KCNH2 Q12809 1/20 0.33
MAP4K1 Q92918 1/20 0.33
SYK P43405 2/20 0.33
FLT4 P35916 2/20 0.31
PTK2 Q05397 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29852461 1.00 CFD (0.47) CFDF11TPSB2KLKB1PLG
SCHEMBL23219142 0.95 CFD (0.49) CFDF11TPSB2KLKB1PLG
SCHEMBL29852684 0.95 CFD (0.49) CFDF11TPSB2KLKB1PLG
SCHEMBL29852868 0.92 CFD (0.47) CFDF11TPSB2KLKB1PLG
SCHEMBL23218766 0.92 CFD (0.47) CFDF11TPSB2KLKB1PLG
SCHEMBL23219177 0.92 CFD (0.43) CFDF11TPSB2KLKB1PLG
SCHEMBL29852544 0.92 CFD (0.43) CFDF11TPSB2KLKB1PLG
SCHEMBL23218774 0.89 CFD (0.37) CFDTBXAS1KCNH2MAP4K1SYK
SCHEMBL29853146 0.89 CFD (0.37) CFDTBXAS1KCNH2MAP4K1SYK
SCHEMBL23218809 0.87 CFD (0.52) CFDF11TPSB2KLKB1PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114502168-A Oral complement factor D inhibitors 拜奥克里斯特制药公司 2022-05-13 CN disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed